EUCTR2012-000967-25-NO进行中（未招募）不适用
Concomitant Radiotherapy and Erlotinib in advanced lung cancerThoRaT-studienThoracal Radiotherapy and Tarceva®An open randomized multicenter phase II study - ThoRaT
未提供0 个研究点开始时间: 2012年5月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Inclusion crieteria
- •Age >18 years
- •Histological or cytological verified NSCLC
- •ECOG Performance status 0-2
- •Fertile patients must use contraception
- •Signed informed consent
- •Ability to understand and fill in QoL questionnaires
- •Capability to take per os medication
- •Serum bilirubin < 2 times upper limit of normal (ULN)
- •AST and ALT < 2 times ULN (< 5 times ULN if liver metastases are present)
- •Creatinine < 5 times ULN
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 125
排除标准
- •Exclusion criteria
- •Pregnancy or nursing
- •Other prior or concurrent malignant disease likely to interfere with study treatment or comparisons
- •No evidence of other significant laboratory finding or concurrent uncontrolled medical illness, that in the opinion of the investigator, would interfere with study treatment or results comparison or render the patient at high risk for treatment complications
- •No prior radiotherapy to the same organ / place
- •No concurrent treatment with other experimental drugs
- •Known brain metastases in need of radiotherapy
研究者
相似试验
终止
2 期
Thoracal Radiotherapy and TarcevaCancerNCT02714530Oslo University Hospital118
Unknown
2 期
Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)Non-small Cell Lung CancerNCT01091376Zhejiang Cancer Hospital75
已完成
2 期
A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell CarcinomaCancerNCT00369512University of Alabama at Birmingham15
Unknown
2 期
Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21Non-small Cell Lung CancerNCT01714908Jinming Yu100
进行中（未招募）
不适用
PHASE I/II TRIAL OF ERLOTINIB, RADIATIONTHERAPY, AND CISPLATIN IN PATIENTS WITH COMPLETE RESECTED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKEnsayo Fase I/II de Erlotinib en combinación con radioterapia y cisplatino en pacientes con carcinoma epidermoide de cabeza y cuello localmente avanzado resecado quirúrgicamenteEUCTR2005-001506-29-ESGroup of Clinical Investigation in Radiotherapy Oncology (GICOR)90